SECTION 1 : CHEMICAL PRODUCT AND COMPANY IDENTIFICATION Product Name Lithium Chloride Product Code 333 001 Synonyms Molecular Weight Chemical Formula Contact Information MFPL Fluorine Products Ltd
E-mail : [email protected] /
SECTION 2 : COMPOSITION / INFORMATION ON INGREDIENTS
Emergency Overview
Warning! harmful if swallowed or inhaled. affects central nervous system, respiratory system,
muscles and kidneys. causes irritation to skin, eyes and respiratory tract. skin irritation may be
SAF-T-DATA(tm) Ratings (Provided here for your convenience)
Lab Protective Equip: GOGGLES; LAB COAT; VENT HOOD; PROPER GLOVES
Storage Color Code: Green (General Storage)
Potential Health Effects Inhalation:
Causes irritation to the respiratory tract. Can be absorbed through inhalation with symptoms to
Ingestion:
Causes irritation to the gastrointestinal tract. Symptoms may include nausea, vomiting and
diarrhea. In severe cases, lithium can cause apathy, sluggishness, drowsiness, slurred speech,
blurred vision, irregular eye movements, weakness, incoordination, lethargy, heart effects, brain
effects, ringing in the ears, tremors and muscle twitching, central nervous system damage,
kidney effects, thyroid changes, coma, pulmonary edema, and renal failure.
Skin Contact:
Causes irritation to skin. Irritation may be severe.
Eye Contact: Chronic Exposure:
Prolonged or repeated ingestion may cause symptoms paralleling ingestion. Death may occur
Aggravation of Pre-existing Conditions:
SECTION 4 : FIRST AID MEASURES Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult,
give oxygen. Call a physician immediately.
Ingestion:
Induce vomiting immediately as directed by medical personnel. Never give anything by mouth to
an unconscious person. Call a physician immediately.
Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes. Remove
contaminated clothing and shoes. Wash clothing before reuse. Call a physician.
Eye Contact:
Wash eyes with plenty of water for at least 15 minutes. Call a physician
SECTION 5 : FIRE-FIGHTINGS MEASURES Fire: Not considered to be a fire hazard. Explosion : Not considered to be an explosion hazard. Fire Extinguishing Media: Use any means suitable for extinguishing surrounding fire. Special Information: In the event of a fire, wear full protective clothing and NIOSH-approved
self-contained breathing apparatus with full facepiece operated in the pressure demand or other
SECTION 6 : ACCIDENTAL RELEASE MEASURES
Ventilate area of leak or spill. Wear appropriate personal protective equipment as specified in
Section 8. Spills: Pick up and place in a suitable container for reclamation or disposal, using a
SECTION 7 : HANDLING AND STORAGE
Keep in a tightly closed container, stored in a cool, dry, ventilated area. Protect against physical
damage. Containers of this material may be hazardous when empty since they retain product
residues (dust, solids); observe all warnings and precautions listed for the product.
SECTION 8 : EXPOSURE CONTROLS / PERSONAL PROTECTION Airborne Exposure Limits: VentilationSystem:
A system of local and/or general exhaust is recommended to keep employee exposures as low as
possible. Local exhaust ventilation is generally preferred because it can control the emissions of
the contaminant at its source, preventing dispersion of it into the general work area. Please refer
to the ACGIH document, Industrial Ventilation, A Manual of Recommended Practices, most
Personal Respirators (NIOSH Approved):
For conditions of use where exposure to dust or mist is apparent and engineering controls are not
feasible, a particulate respirator (NIOSH type N95 or better filters) may be worn. If oil particles
(e.g. lubricants, cutting fluids, glycerine, etc.) are present, use a NIOSH type R or P filter. For
emergencies or instances where the exposure levels are not known, use a full-face positive-
pressure, air-supplied respirator. WARNING: Air-purifying respirators do not protect workers in
Skin Protection:
Wear impervious protective clothing, including boots, gloves, lab coat, apron or coveralls, as
Eye Protection:
Use chemical safety goggles. Maintain eye wash fountain and quick-drench facilities in work
SECTION 9 : PHYSICAL AND CHEMICAL PROPERTIES Appearance White crystals Solubility Specific Gravity
Aqueous solution is neutral or slightly alkaline
% Volatiles by volume @ 21C (70F) 0 Boiling Point Melting Point Vapor Density (Air=1) Vapor Pressure (mm Hg) Evaporation Rate (BuAc=1)
SECTION 10 : STABILITY AND REACTIVITY Stability:
Stable under ordinary conditions of use and storage.
Hazardous Decomposition Products:
Emits toxic fumes of chlorine when heated to decomposition.
Hazardous Polymerization: Incompatibilities: Conditions to Avoid: SECTION 11 : TOXICOLOGICAL INFORMATION Toxicological Data:
Oral rat LD50: 526 mg/kg. Investigated as a tumorigen, mutagen, and reproductive effector.
Reproductive Toxicity:
Has shown some evidence of reproductive effects in laboratory animals. --------\Cancer Lists\------------------------------------------------------ ---NTP Carcinogen--- Ingredient Known Anticipated IARC Category ------------------------------------ ----- ----------- ------------- Lithium Chloride (7447-41-8) No No None SECTION 12 : ECOLOGICAL INFORMATION Environmental Fate: Environmental Toxicity:
Oral (wild bird) LD50: 422 mg/kg (RTECS, 1995)
SECTION 13 : DISPOSAL CONSIDERATIONS
Whatever cannot be saved for recovery or recycling should be managed in an appropriate and
approved waste disposal facility. Processing, use or contamination of this product may change
the waste management options. State and local disposal regulations may differ from federal
disposal regulations. Dispose of container and unused contents in accordance with federal, state
SECTION 14. TRANSPORT INFORMATION SECTION 15 : REGULATORY INFORMATION
--------\Chemical Inventory Status - Part 1\--------------------------------- Ingredient TSCA EC Japan Australia ----------------------------------------------- ---- --- ----- --------- Lithium Chloride (7447-41-8) Yes Yes Yes Yes
-------\Chemical Inventory Status - Part 2\--------------------------------- --Canada-- Ingredient Korea DSL NDSL Phil. ----------------------------------------------- ----- --- ---- ----- Lithium Chloride (7447-41-8) Yes Yes No Yes --------\Federal, State & International Regulations - Part 1\---------------- -SARA 302- ------SARA 313------ Ingredient RQ TPQ List Chemical Catg. ----------------------------------------- --- ----- ---- -------------- Lithium Chloride (7447-41-8) No No No No
--------\Federal, State & International Regulations - Part 2\---------------- -RCRA- -TSCA- Ingredient CERCLA 261.33 8(d) ----------------------------------------- ------ ------ ------ Lithium Chloride (7447-41-8) No No No Chemical Weapons Convention: No TSCA 12(b): No CDTA: No SARA 311/312: Acute: Yes Chronic: Yes Fire: No Pressure: No Reactivity: No (Pure / Solid)
Australian Hazchem Code: None allocated. Poison Schedule: None allocated.
This MSDS has been prepared according to the hazard criteria of the Controlled Products
Regulations (CPR) and the MSDS contains all of the information required by the CPR.
SECTION 16 : OTHER INFORMATION Creation Date : 18.9.2000 Revision Date : 25.7.2006
Disclaimer:
MFPL Fluorine Products Ltd. provides the information contained herein in good faith but makes no representation as to its comprehensiveness or accuracy. This document is intended only as a guide to the appropriate precautionary handling of the material by a properly trained person using this product. Individuals receiving the information must exercise their independent judgment in determining its appropriateness for a particular purpose. MFPL Fluorine Products Ltd MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE WITH RESPECT TO THE INFORMATION SET FORTH HEREIN OR THE PRODUCT TO WHICH THE INFORMATION REFERS. ACCORDINGLY, MFPL Fluorine Products Ltd WILL NOT BE RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF OR RELIANCE UPON THIS INFORMATION
Daniel de Beer Né le 18 octobre 1953 Belge Rue du Viaduc 35 1050 Bruxelles Tél. : + 32.(0)2.646 42 27 Courriel : [email protected] Licencié en droit (1977 - UCL) Docteur en droit (juin 2008 - VUB) Activités professionnelles - professeur invité aux Facultés Universitaires Saint Louis (cours de « Sources et principes du droit » ; séminaire interdisciplinaire et Séminair
International Journal of Drug Design and Discovery Volume 1 • Issue 2 • April– June 2010. 115-123 Synthesis and in vitro Biological Activity of Organic Charge-transfer Complexes of lansoprazole, fluconazole, gabapentin and gabalactum with Chloranilic and Picric Acids Lingappa Mallesha and Kikkeri N. Mohana* Department of Studies in Chemistry, University o